Key Sections of the Scientific Programme

Global Strategies for the Prevention of Mental and Substance Use Disorders

• 1.1. Conceptual foundations of global prevention of mental and substance use disorders
• 1.2. International policy and regulatory frameworks for prevention
• 1.3. Current models and levels of preventive interventions
• 1.4. Social determinants of mental health and the preventive capacity of public health
• 1.5. Innovative approaches to developing prevention programmes
• 1.6. Prospects for improving global prevention strategies

Child and Adolescent Mental Health as a Priority of Preventive Policy

• 2.1. Current challenges to the mental health of children and adolescents
• 2.2. Early diagnosis and prevention of mental and behavioural disorders in childhood
• 2.3. Prevention of suicidal and self-harming behaviour among minors
• 2.4. The impact of the digital environment, social media and cyberbullying on adolescent mental health
• 2.5. Children's mental health in the context of crises, migration and emergencies
• 2.6. Interagency collaboration between healthcare, education and social protection systems in preventing mental disorders
• 2.7. Development of psychological and psychiatric care for children and adolescents in primary healthcare
• 2.8. Innovative technologies and international experience in the prevention of mental and substance use disorders in children and adolescents
• 2.9. Epidemiology of mental disorders in children and adolescents and related prevention strategies
• 2.10. Evidence-based models of early intervention in child psychiatry
• 2.11. Workforce training and development of child and adolescent mental health services

Family as a Resource for the Prevention of Mental and Addictive Disorders

• 3.1. Family as a social institution for the prevention of mental and addictive disorders
• 3.2. Psychosocial mechanisms of family resilience and mental health promotion
• 3.3. Family-centred models of preventive interventions: international experience and the evidence base
• 3.4. Intergenerational transmission of risk factors for mental and addictive disorders
• 3.5. The role of family psychotherapy and psychoeducation in preventing relapse of mental and addictive disorders
• 3.6. Prevention of codependent behaviour and support for patients' relatives
• 3.7. The role of the family in the comprehensive prevention of mental and substance use disorders
• 3.8. State policy on family support as a tool for the prevention of mental and addictive disorders

Anxiety, Depressive and Behavioural Disorders: Diagnosis, Therapy and Early Prevention

• 4.1. Transdiagnostic approaches to anxiety, depressive and behavioural disorders
• 4.2. Biomarkers and digital phenotypes in the early diagnosis of emotional disorders
• 4.3. Evidence-based psychopharmacotherapy and modern psychotherapeutic technologies
• 4.4. Early interventions in psychiatry: from risk factors to disease prevention
• 4.5. Neurodevelopment and emotional-behavioural disorders in children and adolescents
• 4.6. Comorbidity of anxiety, affective and addictive disorders: an interdisciplinary approach
• 4.7. Prevention of relapse and restoration of mental health
• 4.8. Innovations in the diagnosis and treatment of anxiety and depressive disorders: digital medicine and artificial intelligence

Prevention of Suicidal Behaviour: International Experience and Regional Practices

• 5.1. Modern concepts in suicidology: from risk assessment to personalised prevention
• 5.2. Biological, psychological and social determinants of suicidal behaviour
• 5.3. Evidence-based models for early intervention in suicidal crises
• 5.4. Crisis intervention and care pathways for patients at high suicide risk
• 5.5. Prevention of repeat suicide attempts and long-term patient follow-up
• 5.6. The role of family, educational institutions and local communities in preventing suicidal behaviour
• 5.7. The impact of the digital environment, social media and media content on suicide risk
• 5.8. International experience and regional practices in organising suicide prevention services

Public Mental Health and the Development of Resilient Communities

• 6.1. Public mental health in the context of the Sustainable Development Goals
• 6.2. Population-based strategies for the prevention of mental disorders
• 6.3. Mental wellbeing, resilience and social capital of communities
• 6.4. Organisation of public mental health services: international experience and national models
• 6.5. Mental health of vulnerable population groups and issues of social inclusion
• 6.6. Contemporary strategies to combat stigma and discrimination
• 6.7. Workforce development and interdisciplinary collaboration in public mental health
• 6.8. Innovation, digital health and artificial intelligence in advancing public mental health

Interagency Collaboration in the Prevention of Mental Disorders and Addictions

• 7.1. State policy and interagency governance in the field of mental health
• 7.2. Integrated models for the prevention of mental and addictive disorders
• 7.3. Intersectoral collaboration in the implementation of prevention programmes: healthcare, education, social protection and NGOs
• 7.4. Coordination of services in providing care to high-risk groups
• 7.5. Legal and regulatory aspects of interagency collaboration in mental health
• 7.6. Coordinated care pathways and continuity of preventive and treatment services
• 7.7. Digital transformation of interagency collaboration: data exchange, telemedicine and analytical systems
• 7.8. Evaluation of the effectiveness of interagency prevention programmes and performance indicators

Digital Solutions and Artificial Intelligence in Preventive Psychiatry and Addiction Medicine

• 8.1. Digital transformation of preventive psychiatry and addiction medicine: new opportunities and challenges
• 8.2. Artificial intelligence and machine learning for predicting mental and addictive disorders
• 8.3. Personalised prevention based on digital data and precision medicine technologies
• 8.4. Digital therapeutics (DTx) in prevention and early intervention
• 8.5. Intelligent clinical decision support systems in psychiatry and addiction medicine
• 8.6. Integration of artificial intelligence into primary healthcare and public health
• 8.7. Cybersecurity, personal data protection and issues of trust in digital medical technologies
• 8.8. The future of preventive psychiatry: digital ecosystems, generative artificial intelligence and international cooperation

Psychotic Disorders and Schizophrenia

• 9.1. Current understanding of the pathogenesis of psychotic disorders and schizophrenia
• 9.2. Biomarkers, neuroimaging and genetic research in psychosis
• 9.3. Early intervention programmes for first-episode psychosis
• 9.4. Personalised treatment and treatment-resistant schizophrenia: current therapeutic strategies
• 9.5. Negative symptoms and cognitive deficits: new therapeutic approaches
• 9.6. Rehabilitation, recovery and recovery-oriented models of psychiatric care
• 9.7. Relapse prevention and improving treatment adherence
• 9.8. Organisation of specialised care for patients with psychotic disorders: international experience and national models

Workforce Training and Education in Psychiatry and Addiction Medicine

• 10.1. Strategic directions for the development of education in psychiatry and addiction medicine
• 10.2. Competencies of the 21st-century specialist: clinical, research, communication and digital skills
• 10.3. Artificial intelligence and digital educational technologies in the training of psychiatrists and addiction specialists
• 10.4. Development of teaching capacity and leadership in medical education
• 10.5. Workforce training for preventive psychiatry, addiction medicine and public mental health
• 10.6. International cooperation, academic mobility and joint educational programmes

Economics of Prevention: Investing in Population Mental Health

• 11.1. Mental health economics within the public health system
• 11.2. Investment in prevention as a tool for reducing the socioeconomic burden of mental and addictive disorders
• 11.3. Methods of economic evaluation in psychiatry and addiction medicine: cost-effectiveness, cost-utility and cost-benefit analysis
• 11.4. Building sustainable financing models for prevention programmes
• 11.5. The economics of early intervention and mental disorder prevention
• 11.6. Mental health and workforce productivity: impact on human capital and economic growth
• 11.7. Intersectoral investment in mental health: healthcare, education, social protection and the labour market
• 11.8. State policy and international experience in financing mental health promotion programmes

Affective (Mood) Disorders

• 12.1. Contemporary understanding of affective disorders: from clinical phenotypes to personalised psychiatry
• 12.2. Depressive disorders: new approaches to diagnosis and therapy
• 12.3. Bipolar affective disorder: current diagnostic criteria and treatment strategies
• 12.4. Treatment-resistant depression: causes, predictors and current therapeutic strategies
• 12.5. Affective disorders across the lifespan: children, adolescents, adults and older adults
• 12.6. Modern psychopharmacotherapy of depression and bipolar disorder
• 12.7. Non-pharmacological treatments for affective disorders: psychotherapy, neuromodulation and digital technologies
• 12.8. Biomarkers and predictors of treatment efficacy in affective disorders
• 12.9. Neurotic, stress-related and somatoform disorders

Biological Psychiatry, Neuroscience and Modern Treatment Methods

• 13.1. Neurobiology of mental disorders: current models and concepts
• 13.2. Neuroimaging and neural networks in psychiatry
• 13.3. Neuroplasticity and mechanisms of recovery
• 13.4. Genetics, epigenetics and pharmacogenomics
• 13.5. Neuroimmunology and inflammatory mechanisms
• 13.6. Biomarkers and personalised psychiatry
• 13.7. Innovative psychopharmacotherapy and novel therapeutic targets
• 13.8. Neuromodulation: ECT, TMS and emerging technologies
• 13.9. Artificial intelligence and digital technologies in psychiatry

Special Populations and Interdisciplinary Psychiatry

• 14.1. Mental health of children and adolescents: from early detection to prevention
• 14.2. Perinatal and women's psychiatry: current approaches
• 14.3. Geriatric psychiatry and neurocognitive disorders
• 14.4. Psychosomatic medicine and the integration of psychiatry with general medicine
• 14.5. Cardiopsychiatry, oncopsychiatry and other areas of consultation-liaison psychiatry
• 14.6. Mental health of socially vulnerable groups
• 14.7. Psychiatric care in the context of crises, disasters and emergencies
• 14.8. Mental health of healthcare workers and prevention of occupational burnout

Ethics, Human Rights, Emergency and Forensic Psychiatry

• 15.1. Human rights as the foundation of modern psychiatric care
• 15.2. Involuntary care: balancing safety and patient rights
• 15.3. Ethical challenges of digital and personalised psychiatry
• 15.4. Emergency psychiatry: assessment of suicide, violence and offending risk
• 15.5. Psychiatric care in emergencies and humanitarian crises
• 15.6. Modern forensic psychiatric assessment
• 15.7. Assessment of criminal responsibility and fitness to stand trial
• 15.8. Risk assessment for dangerous behaviour and prevention of reoffending
• 15.9. Compulsory medical measures: clinical and legal aspects
• 15.10. Ethics, law and interagency collaboration in modern psychiatry

Other Topics in Psychiatry and Addiction Medicine